+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability

HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability

Cancer Cell 8(2): 143-153

Individuals with hemizygous germline fumarate hydratase (FH) mutations are predisposed to renal cancer. These tumors predominantly exhibit functional inactivation of the remaining wild-type allele, implicating FH inactivation as a tumor-promoting event. Hypoxia-inducible factors are expressed in many cancers and are increased in clear cell renal carcinomas. Under normoxia, the HIFs are labile due to VHL-dependent proteasomal degradation, but stabilization occurs under hypoxia due to inactivation of HIF prolyl hydroxylase (HPH), which prevents HIF hydroxylation and VHL recognition. We demonstrate that FH inhibition, together with elevated intracellular fumarate, coincides with HIF upregulation. Further, we show that fumarate acts as a competitive inhibitor of HPH. These data delineate a novel fumarate-dependent pathway for regulating HPH activity and HIF protein levels.

(PDF emailed within 0-6 h: $19.90)

Accession: 012135762

Download citation: RISBibTeXText

PMID: 16098467

DOI: 10.1016/j.ccr.2005.06.017

Related references

Fumarate Hydratase-deficient Renal Cell Carcinoma Is Strongly Correlated With Fumarate Hydratase Mutation and Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome. American Journal of Surgical Pathology 40(7): 865-875, 2017

The complex allosteric and redox regulation of the fumarate hydratase and malate dehydratase reactions of Arabidopsis thaliana Fumarase 1 and 2 gives clues for understanding the massive accumulation of fumarate. Febs Journal 285(12): 2205-2224, 2018

Specificity of fumarate hydratase. I. Formation of oxalacetate from unnatural (--)-tartrate by fumarate hydratase. Journal of Biological Chemistry 243(3): 528-532, 1968

Fumarate Mediates a Chronic Proliferative Signal in Fumarate Hydratase-Inactivated Cancer Cells by Increasing Transcription and Translation of Ferritin Genes. Molecular and Cellular Biology 37(11), 2017

HIF and fumarate hydratase in renal cancer. British Journal of Cancer 96(3): 403-407, 2007

Biallelic inactivation of fumarate hydratase (FH) occurs in nonsyndromic uterine leiomyomas but is rare in other tumors. American Journal of Pathology 164(1): 17-22, 2003

Conventional renal cancer in a patient with fumarate hydratase mutation. Human Pathology 38(5): 793-796, 2007

Mutations in fumarate hydratase during cutaneous and uterine leiomyomatosis associated with renal cancer. Annales de Dermatologie et de Venereologie 132(3): 300, 2005

A role for cytosolic fumarate hydratase in urea cycle metabolism and renal neoplasia. Cell Reports 3(5): 1440-1448, 2013

Post-translational regulation of metabolism in fumarate hydratase deficient cancer cells. Metabolic Engineering 45: 149-157, 2017

Absence of fumarate hydratase mutation in a family with cutaneous leiomyosarcoma and renal cancer. International Journal of Dermatology 47 Suppl 1: 18-20, 2008

Downregulation of fumarate hydratase is related to tumorigenesis in sporadic renal cell cancer. Urologia Internationalis 90(2): 233-239, 2013

Loss of Fumarate Hydratase and Aberrant Protein Succination Detected With S-(2-Succino)-Cysteine Staining to Identify Patients With Multiple Cutaneous and Uterine Leiomyomatosis and Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome. American Journal of Dermatopathology 38(12): 887-891, 2016

Missense mutations in fumarate hydratase in multiple cutaneous and uterine leiomyomatosis and renal cell cancer. Journal of Molecular Diagnostics 7(4): 437-443, 2005

Hereditary leiomyomatosis and renal cell cancer in families referred for fumarate hydratase germline mutation analysis. Clinical Genetics 79(1): 49-59, 2011